Long awaited HIV treatment guidelines released for public comment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply. NLM AIDSLINE Important note: Information in this article was accurate in 1997. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Long awaited HIV treatment guidelines released for public comment. Clearinghouse, AIDS Newsletter Database, P.O. Box 6003, Rockville, MD 20849-6003. 800-458-5231 ext. 5714. A fee will apply.

Crit Path AIDS Proj. 1997 Summer;(No 32):1, 9-14. Unique Identifier : AIDSLINE MED/97702721


Abstract: The long-awaited AIDS treatment guidelines were published on June 19, replacing the obsolete guidelines written in 1993. The earlier guidelines, written before the development of viral load testing and protease inhibitors, recommended sub-optimal treatment using one or two drugs. The new model calls for potent triple combination therapy, reducing HIV to below-detectable levels, managing care via viral load testing, and strict adherence to treatment regimens. A summary of the principals of therapy and the guidelines for use of antiretroviral agents is included. The full guidelines are available in the Federal Register.
Keywords: *Anti-HIV Agents/THERAPEUTIC USE *HIV Infections/DRUG THERAPY *HIV Protease Inhibitors/THERAPEUTIC USE *Reverse Transcriptase Inhibitors/THERAPEUTIC USEKWDanti-hivagents/therapeuticuseKWDhivinfections/drugtherapyKWDhivproteaseinhibitors/therapeuticuseKWDreversetranscriptaseinhibitors/therapeuticuse
971230
M97C1594

Copyright © 1997 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1997. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1997. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .